Correlation Of Body Mass Index  With Prostate Volume In Benign Prostatic Hyperplasia Patients by Tritanto, Rio et al.
Correlation of Body Mass Index…   Trtitanto R, Arifin F, Prajitno S	
	 19 
CORRELATION OF BODY MASS INDEX  WITH PROSTATE VOLUME IN 
BENIGN PROSTATIC HYPERPLASIA PATIENTS 
Rio Tritanto1), Fransiscus Arifin2), Subur Prajitno3) 
 
Introduction: Benign prostatic hyperplasia (BPH) is the most common prostatic disease in 
men. Multiple factors influence the pathogenesis of BPH, and one of them is obesity. Various 
studies about the correlation between obesity and prostate volume show inconsistent results. 
Some studies reported that obesity correlates with prostate volume, whereas others didn't find 
the correlation between obesity and prostate volume. Therefore, this study aims to find the 
correlation between obesity and prostate volume.  
Purpose: To find the relationship between body mass index (BMI) and BPH patients' 
prostate volume.  
Methods: BMI was measured by BMI formula, and prostate volume was measured by 
transabdominal ultrasound (TAUS). This study was conducted in RSUD Ibnu Sina 
Kabupaten Gresik by looking at medical records in January 2016-September 2017. This study 
was an analytical observational study with a cross-sectional approach. This study uses Linear 
Regression Test to analyze the correlation of in-between variables. This study's population 
was patients with a diagnosis of BPH that undergo hospitalization in RSUD Ibnu Sina (273 
medical records). The study sample that corresponding to inclusion and exclusion criteria are 
27 medical records.  
Result: The average prostate volume in underweight criteria was 44,5 cm3, in normal criteria 
is 42,4 cm3. Highest average of prostate volume found in overweight criteria, which was 64,3 
cm3. In the obese criteria, the average prostate volume was 32,2 cm3. The average prostate 
volume was 46,0 cm3. From the linear regression test, we found the value of p=0,881 and 
R2=0,01.  
Conclusion: There is no significant correlation between BMI and prostate volume in this 
study 
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Progress in the health sector today 
has not been accompanied by health 
awareness in the community. According 
to population census data, Indonesia's life 
expectancy has increased from 1971, 
namely 45.7 years old, to 70.7 years old in 
2010. The female's life expectancy is 
higher (72.6 years old) than the male's life 
expectancy (68,7 years old)1. Although 
the life expectancy has increased, the 
trend of obesity has also increased 
significantly. According to RISKESDAS 
2013, the prevalence of obese adult male 
population in 2013 was 19.7 percent, 
higher than in 2007 (13.9%) and 2010 
(7.8%). 2 
 Obesity in adult society causes 
increased health problems, such as 
cardiovascular disease, type 2 diabetes 
mellitus, osteoarthritis, hypertension, and 
dyslipidemia3. Obese men also experience 
prostate disease (prostatitis, benign 
prostatic hyperplasia (BPH), and prostate 
cancer). 
 The prostate gland is an organ in 
men that most often undergoes neoplastic 
changes, both benign and malignant. 
Benign prostatic hyperplasia (BPH) is the 
most common benign tumor that grows in 
men, and the incidence is related to age. 
The prevalence of BPH on autopsy 
examinationhistologically increased by 
20% at 41-50 years old, 50% at 51-60 
years old, and more than 90% in patients 
over 80 years old. Although clinically less 
frequent, the symptoms caused by a 
prostate obstruction are also age-related. 
At 55 years old, 25% of men reported 
experiencing obstructive voiding 
symptoms, by the age of 75 years old, 
50% of men complained of experiencing a 
decrease in the urine flow's strength. 
BPH occurs in the transitional 
zone and causes obstruction of the bladder 
neck and urethra, known as bladder outlet 
obstruction (BOO). BOO caused 
specifically by BPH is known as benign 
prostate obstruction (BPO). This 
enlargement causes BPH patients to 
develop Lower Urinary Tract Symptoms 
(LUTS), which consists of symptoms and 
signs of obstruction and irritation. 6 
Symptoms and signs of urinary 
tract obstruction are that the patient has to 
wait for the first urinary discharge, 
interrupted micturition, dripping at the 
end of the micturition, weakened 
micturition, and feeling unsatisfied after 
micturition. Symptoms of irritation due to 
the detrusor muscle's hypersensitivity 
mean increased frequency of micturition, 
nocturia, difficulty tolerating micturition, 
and dysuria. The obstruction occurs 
because the detrusor fails to contract 
strongly enough or fails to acquire long 
Correlation of Body Mass Index…   Trtitanto R, Arifin F, Prajitno S	
	 21 
enough intermittent contractions. The 
symptoms of irritation occur due to 
incomplete emptying at the time of 
urination or enlargement of the prostate, 
stimulating the bladder. The bladder often 
contracts even though it is not yet full. 
These symptoms and signs are scored and 
expressed in the form of I-PASS 
(International Prostate Symptoms Score). 
7 
 Apart from using I-PASS, other 
tests that can be used in determining the 
diagnosis of BPH are digital rectal, 
measuring the remaining urine after 
urination with catheterization or 
ultrasound of the bladder, uroflowmetry 
to measure the strength of the urine 
emission at the time of urination, or with 
an ultrasound imaging modality to 
determine the size of the prostate.7 
Theoretically, in obese patients, 
adipose tissue causes an increase in 
estrogen due to the aromatization of 
testosterone. This change in hormonal 
balance plays a role in the pathogenesis of 
BPH.8 Another conceptual approach is 
that obesity causes systemic inflammation 
and occurs in the prostate tissue resulting 
in the enlargement of prostate size. 
several studies show that obesity plays a 
role in prostate gland enlargement3,4,10,11, 
but several other studies do not show the 
role of obesity in the prostate gland's 
enlargement3,12,13,14. Obesity can be 
measured by calculating the body mass 
index. Because of the discrapency in the 
previous studies results, the researchers 
wanted to prove that the increase in BMI 
would be followed by an enlargement of 
the prostate volume in BPH patients with 
transabdominal ultrasonography (TAUS) 
examination at Ibnu Sina Regional 
Hospital, Gresik Regency. 
 
METHODS 
this research is an observational 
study. data was analyzed using the cross-
sectional method. This study took medical 
record data of BPH patients at the Ibnu 
Sina Regional Hospital, Gresik Regency, 
from January 2016 to September 2017. 
This study's population were all BPH 
patients hospitalized at the Ibnu Sina 
Regional Hospital, Gresik Regency during 
the period January 2016 to September 
2017. The research sample was BPH 
patients at the Ibnu Sina Hospital, Gresik 
Regency, from January 2016 to 
September 2017 who met the inclusion 
criteria and were not included in the 
exclusion criteria. This study's inclusion 
criteria were patients with a radiological 
diagnosis of BPH, and data on height, 
weight, and prostate volume were 
obtained by TAUS examination. This 
study's exclusion criteria were patients 
with prostate cancer, prostatitis patients, 
incomplete medical records, and patients 




over 65 years of age. The sampling 
technique was non-probability sampling 
through purposive sampling. Purposive 
sampling is data collection based on the 
researcher's assessment criteria, 
considering that the sample meets the 
inclusion requirements and follows the 
research objectives. The minimum sample 
size for this study was 22 samples. In this 
study, out of 105 medical records, there 
were 84 medical records with weight and 
height data, from 84 medical records, 
there were 27 medical records that had 
complete prostate volume data (height, 
width, and length), four medical records 
only had data for length and height, one 
medical record only has width data, and 
52 medical records have no data. 
Therefore, the number of samples 
analyzed was 27 medical records that 
matched the inclusion and exclusion 
criteria. 
Based on the data collection that has 
been carried out, the data obtained are 
described in the table of age, weight, 
height, body mass index, and prostate 
volume. we used a linear regression test 
with the equation y = a + bx to examine 
how much the BMI variable will affect 
the prostate volume variable..  
 
RESULT 
The number of BPH patients at Ibnu 
Sina Hospital in 2016 was 158 people, 
and from January 2017 to September 
2017 was 115 people. The total number of 
BPH patients in Ibnu Sina from 2016 to 
September 2017 was 273 people. 
However, the number of BPH patients 
who had complete prostate volume data 
was 27. 
Table 1 Number of BPH Patients in 2016 and 
2017 at Ibnu Sina Regional Hospital 








Diagram 1 Percentage of BPH Patients by Age Group 
at Ibnu Sina Gresik Regional Hospital January 2016-
September 2017 
 
Diagram 1 shows the percentage of BPH 
patients by age group at the Ibnu Sina 
Gresik Regional Hospital from January 
2016 to September 2017. The age group 
with the least percentage of BPH patients 
is the age group 25-44 years, with 1% (3 
people). The age group with the second-
highest percentage of BPH patients was 
45-65 years old with 44% (120 people), 
and the age group with the highest 
1%	
44%	55%	
Percentage of BPH Patients by Age Group at 
Ibnu Sina Gresik Regional Hospital January 
2016-September 2017 
25-44	 45-65	 >65	
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percentage was over 65 years old with 
55% (150 people). 
Table 2 BMI Distribution Table of BPH Patients Who 
Have Complete Prostate Volume Data 














Table 3 Distribution of BMI Data Distribution of 
BPH Patients Who Have Complete Prostate 
Volume Data 
 
















Table 2 shows the number of BPH 
patients with body mass index data with 
complete prostate volume; there were 27 
patients. The highest number of BPH 
patients was in the normal category, as 
many as 16 people, and the least number 
of BPH patients were in the obese 
category, where there were two people. In 
the skinny category, there are four people, 
and the overweight category is over five 
people. 
Table 3 shows the distribution of the 
BMI data distribution of BPH patients 
who have complete prostate volume data. 
The average was 22.46 kg/m2, median 
22.03 kg/m2, mode 16.11 kg/m2, patients 
with the smallest BMI was 16.11 kg/m2, 
the patient with the largest BMI was 
31.22 kg/m2, the standard deviation value 
was 3.61, and the number of patients was 
27. 
To calculate the volume of the 
prostate, use the ellipsoid formula, which 
is by knowing the largest anteroposterior 
height (H), transverse width (W), 
cephalocaudal length (L), then entering 
into the formula: 𝑉𝑜𝑙𝑢𝑚𝑒 = 𝐻 × 𝑤 × 𝐿×
!
!
 . The greatest anteroposterior height 
(H), transverse width (W), cephalocaudal 
length (L) are known from ultrasound 
examination. The ultrasound machine 
used was the Toshiba Aplio 400. 
 
Figure 1 Prostate ultrasound image 
 
From the prostate ultrasound image 
above, we can determine a BPH patient's 
prostate volume, where line A is the 
largest anteroposterior (H) height, 
measuring 47.1 mm. Line B is 
cephalocaudal (L) length, measuring 40.2 
mm. Line C is the transverse width (W), 
measuring 50.6 mm. Then these numbers 
are entered into the formula ellipsoid: 








𝑉𝑜𝑙𝑢𝑚𝑒 = 50.164 𝑚𝑚! = 50,164 𝑐𝑚!;  




then the prostate volume above is 50.164 
cm3. 
 
Table 4 Prostate Volume Distribution Table for 
BPH Patients Who Have Complete Prostate 
Volume Data 
Volume 













Total  27 
Table 5 Prostate Volume Grading Distribution 
Table based on BMI 
 
 
Table 6 Table of Average Prostate Size Volume 











Mean Total 46,0 cm3 
 
Table 4 shows that the highest number 
of BPH patients according to prostate 
volume grading was at Grade III with 11 
people, and the least number was at Grade 
IV with one person. The number of BPH 
patients with Grade I was six and Grade II 
was 9. 
From Table 5, the highest prostate 
volume grade in the thin BMI group was 
grade II with a rate of 3 people (11.1%). 
The highest prostate volume grade in the 
group with normal BMI was Grade III 
with eight people (29.6%). Only one 
person (3.7%) had Grade IV. 
Table 6 explains that in the thin 
category group, the mean prostate volume 
was 44.5 cm3; in the normal category, it 
was 42.4 cm3. The largest mean prostate 
volume was found in the overweight 
category group, namely 64.3 cm3. In the 
obese group, the mean prostate volume 
was 32.2 cm3. The overall mean of BPH 
patients at the Ibnu Sina Regional 
Hospital was 46.0 cm3. 
To examine how much the BMI 
variable will affect the prostate volume 
variable, the researcher will use a linear 
regression test with equations 𝑦 = 𝑎 +
𝑏𝑥.  
In this study it was found that the data 
have normal distribution values. The BMI 
variable has a Skewness value = 0.92; 
Kurtosis = 0.32; and Shapiro-Wilk = 
0.758. The prostate volume variable has a 
Skewness value = 0.95; Kurtosis = -0.07; 
and Shapiro-Wilk = 0.787. 
To find out whether the data on the 
variables in this study had a homogeneous 
variant, the Levene test was used. In the 
Levene test, the variable prostate volume 
has a value of p = 0.232, and the BMI 
variable is p = 0.302. Because both 
variables have p> 0.05, the two variables 
have a homogeneous variant. 
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From the results of the regression 
calculation according to the IBM SPSS 
Statistic 24 program, it was found that p-
value = 0.881, which can be concluded 
that there is no significant relationship 
between BMI and prostate volume. 
Because there was no significant 
relationship between BMI and prostate 
volume, a regression equation between 
BMI and prostate volume could not be 
made. The scatter diagram found that the 
data distribution between prostate volume 
(y-axis) and BMI (x-axis) were randomly 




Based on the data obtained from the 
index of BPH inpatients at the Ibnu 
Sina Hospital, Gresik Regency, we can 
find out the number of patients and the 
patients' age in the period January 2016 
to September 2017. Out of 273 people, 
the number of BPH patients is in the 
25-44 years old group. There were 
three people (1.1%), in the 45-65 years 
age group, there were 120 people 
(44%), and in the age group over 65 
years old, there were 150 people 
(55%). This result shows similarities 
with other studies that there is an 
increase in BPH incidence with age. 
In this study, from 105 medical 
record files submitted to researchers, 
seven medical records were sampled in 
the study because they had complete 
data on height, weight, prostate volume 
and were under the inclusion and 
exclusion criteria. Four people had a 
BMI under 18.5 and were categorized 
as skinny, 16 people had a BMI 
between 18.5 and 24.9 and were 
categorized as normal, and five people 
had a BMI between 25 and 27 and 
were categorized as overweight. Two 
people were included in the obese 
category because they had a BMI 
above 27. The number of obese 
patients in this study was two, which is 
one of the study's weaknesses because 
the number is small and does not 
represent the obese BMI group. This 
study's limitation was that not all 
medical records had complete prostate 
volume data, and only two obese 
patients had complete prostate volume 
data. This incomplete medical record 
data also causes researchers to be 
unable to use probability sampling 
techniques (stratified random 
sampling). 
The BMI table data distribution 
shows that the mode values do not 
approach the mean and median values 
because the BMI distribution has a 
multimodal distribution and does not 
have twin values. 




Prostate volume was obtained 
using the ellipsoid formula after 
knowing the largest anteroposterior 
height (H), transverse width (W), 
cephalocaudal length (L) from 
ultrasound examination. The 
ultrasound machine used in this 
examination is the Toshiba Aplio 100 
with the TAUS examination method. 
If divided into 4 grades, the 
classification of prostate volume 
grading is as follows: 
Table 7 Classification of Prostate 
Volume 









In this study, of 27 people, there 
were six people with grade I BPH, nine 
people with grade II BPH, 11 people 
with grade III BPH, and one with grade 
IV BPH. The patient with the smallest 
prostate volume was 12.01 cm3, while 
the patient with the largest prostate 
volume was 94.1 cm3. The mean 
prostate volume of BPH patients in this 
study was 46.0 cm3. The prostate 
volume table's data distribution shows 
that the mode values do not approach 
the mean and median values because 
the prostate volume distribution has a 
multimodal distribution and does not 
have twin values. 
The mean prostate volume in 
patients with an obese BMI category 
(32.2 cm3) was smaller than that of the 
other BMI category groups and does 
not follow the existing theory. This 
could be due to decreased quality of 
ultrasound imaging results in obese 
patients so that the prostate volume is 
found to be less accurate. In obese 
patients, sound waves attenuate due to 
thick adipose tissue. Increased 
attenuation of sound waves goes 
straight along with an increase in the 
thickness of the adipose tissue. The 
higher the frequency used, the higher 
the attenuation of sound waves. The 
difference in the thickness of the fat 
layer also causes the speed of sound 
that passes through the adipose tissue 
to be different, and when received by a 
transducer, it will reduce the quality of 
the ultrasound imaging results. 
In this study, we wanted to 
determine how much the BMI variable 
would affect the prostate volume 
variable to use a linear regression test 
with the equation y = a + bx. For the 
linear regression test to be carried out, 
the parametric test research 
requirements must be met, namely 
having a normal distribution and a 
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homogeneous data variant. Based on 
the values of Skewness, Kurtosis, and 
Shapiro-Wilk, it was found that the 
data for the two variables had a normal 
distribution. Based on the Levene test 
shows that the two variables have a 
homogeneous variant. Furthermore, the 
linear regression test was carried out, 
from the results of the linear regression 
test, the value of p = 0.881 or p> 0.05. 
The p value> 0.05 indicates that 
prostate volume and body mass index 
do not have a significant relationship, 
with a value of R2 = 0.01, which 
means that the effect of BMI on 
prostate volume is 1%. This result is 
under the research conducted by 
Ambeng Y., et al., which was 
conducted in Dr. Soetomo Surabaya, 
which showed that there was no 
significant relationship between BMI 
and prostate volume (r = 0.018 and p = 
0.936) 18, but research conducted by 
Yelsel K., et al. showed different 
results, where the study they conducted 
showed that BMI has a positive 
correlation with prostate volume (r = 
0.630 and P <0.001) .10 
The study's difference could be 
due to differences in the characteristics 
of the study sample, the number of the 
study sample, and the methods of 
measuring prostate volume and BMI 
used in the study. In a study conducted 
by Yelsel K. et al., Patients who were 
sampled had an age range of 56-90 
years; wherein this study, the sample 
used was patients under 65 years of 
age to minimize the age factor on 
prostate volume. Research conducted 
by Yelsel K. et al., Excluded patients 
who took 5-α-reductase inhibitors or 
antiandrogens because they could 
affect prostate volume, whereas, in this 
study, the consumption of 5-α-
reductase inhibitors or antiandrogens 
were not excluded. 
Because it uses a broader age 
range, in the study of Yelsel K., et al., 
the sample used was larger, namely 
211 people, while in this study due to 
the lack of complete data in the 
medical record archives, the number of 
research samples was only 27 people. 
The difference in the number of 
samples in the study also affects the 
results of the investigation. 
The Ibnu Sina Hospital's 
ultrasound machine used in this study 
was the Toshiba Aplio 400. In contrast, 
Yelsel K. et al. did not include the 
ultrasound machine. The method of 
measuring prostate volume used in this 
study was Transabdominal Ultrasound 
(TAUS), while the study conducted by 
Yelsel K., et al., used the Trans Rectal 
Ultrasound (TRUS) examination. 
Although TRUS may be better at 




estimating prostate size, Sutapa et al. 
did not show a significant difference 
between the measurement of prostate 
volume using the TRUS method and 
the TAUS method. Examination using 
ultrasound is very dependent on 
operator expertise (operator-
dependent) so that the results of the 
examination can be different from one 
person to another. We used the Kappa 
coefficient test to find the degree of 
consistency of the results of ultrasound 
examinations carried out by more than 
one examiner. 
The weight and height used in this 
study were only by recording what was 
stated in the medical records so that 
researchers could not measure the 
errors that occurred when measuring 
height and weight. Errors that occur 
during this measurement can cause 
errors in calculating the patient's BMI. 
In a study conducted by Yelsel K. et 
al., measurement of body weight and 
height was carried out for the sake of 
research to measure errors that can 
occur during measurement. The timing 
of BMI data collection was also a 
factor that led to the absence of a 
significant relationship between BMI 
and prostate volume. We cannot see 
whether the BMI the patient has was 
temporary or has been since the 
incident or before BPH appeared14. 
The following are differences in 
several factors that can affect the 
differences in the results of the two 
studies: 
Table 8. Research Differences between 
Tritanto R. dan Yelsel K., et al 
Items Tritanto R. Yelsel K., 
et al. 
Age mean 59,61 68.0 ± 6.3 
Age range 48-65 56-90 




USG Machine Toshiba Aplio 
400 
None 








reductase inhibitors or 
antiandrogens 
Not excluded Excluded 
Bladder stones Not excluded Excluded 
Neurogenic bladder 
dysfunction 
Not excluded Excluded 
Reapeated ISK Not excluded Excluded 
 
Apart from the method and 
method of data collection, other 
confounding variables may affect the 
finding of insignificant relationship 
between BMI and prostate volume. 
Metabolic syndrome such as insulin 
resistance can affect prostate growth. 
In insulin resistance conditions, there is 
a decrease in cell response to insulin so 
that pancreatic beta cells will produce 
more insulin and hyperinsulinemia 
occurs.21 Insulin is known as a mitogen 
and becomes a growth factor for 
prostate epithelial cells. Increased 
insulin will lead to increased 
transcription of genes involved in sex 
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hormone metabolism. 
Hyperinsulinemia is also associated 
with decreased sex hormone-binding 
globulin, resulting in an increase in the 
number of androgens and estrogens in 
the prostate and an increased BPH risk. 
Insulin-like growth factor 1 (IGF-
1) also promotes prostate epithelial 
growth. Homologous insulin receptors 
with IGF-1 receptors, so that insulin 
can bind to the IGF-1 receptor and 
activate the IGF signaling pathway that 
promotes prostate growth.22 Nandeesha 
et al. found that insulin was an 
independent risk factor for increased 
prostate volume. Patients with fasting 
plasma insulin levels less than 7mU / 
mL had prostate growth of 0.84 mL per 
year, whereas patients with 




Research on the correlation between BMI 
and prostate volume in BPH patients at 
the Gresik District Hospital can be 
concluded as follows: 
1. The number of BPH patients in the 
25-44-year-old age group is three 
people (1.1%), in the 45-65-year-old 
age group, there are 120 people 
(44%), and in the age group over 65 
years old, there are 150 people (55 
%). There is an increase in the 
incidence of BPH with increasing 
age. 
2. The average prostate size in BPH 
patients at the Ibnu Sina Regional 
Hospital, Gresik Regency, is 46 cm3. 
3. There is no correlation between BMI 
and prostate volume in BPH patients. 
Based on the research that has been done, 
there are several suggestions for further 
study. 
1. Improve the sample distribution of 
each BMI group so that the study 
results are representative of each BMI 
group and the results obtained have 
better statistical power. Hospitals and 
clinicians' role is to complete data 
and carry out more complete 
examinations so that all medical 
records can be used and provide 
better research results. 
2. Measuring body weight and height 
directly to minimize the measurement 
error factor. 
3. In this study, researchers found it 
difficult to get complete prostate 
volume data from ultrasound 
machine. For further research, it is 
recommended that the researcher 
communicates with the clinician 
(surgeon and/or radiologist) who 
treats and examines the patient so that 
they know the picture or approximate 
sample that will be met during the 
study. 
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